Table 1.
Baseline clinicopathological characteristics of the TCGA-THCA cohort (n=450).
| Characteristic | Value |
|---|---|
| Age (years), Median [IQR] | 46 [35-59] |
| Gender, n (%) | |
| Male | 122 (27.1) |
| Female | 328 (72.9) |
| Pathological Stage, n (%) | |
| Stage I | 248 (55.1) |
| Stage II | 59 (13.1) |
| Stage III | 95 (21.1) |
| Stage IV | 48 (10.7) |
| Tumor Status at last follow-up, n (%) | |
| Tumor Free | 401 (89.1) |
| With Tumor | 49 (10.9) |
| Vital Status, n (%) | |
| Alive | 425 (94.4) |
| Deceased | 25 (5.6) |
Data are presented as median [interquartile range, IQR] or number (%).